Moderna Gains 9% Ahead of Wall Street Open; Insiders Buy $6M in Shares 💡

Moderna (MRNA.US) stock is up nearly 9% ahead of Wall Street's open today after the company's CEO and a board member bought a combined $6 million worth of shares. Moderna's stock is down about 27% since the beginning of the year, so the insider update is improving investor sentiment around the company.

Nominally, the latest purchases were among the largest in many years. Source: Bloomberg Financial LP

The company's stock is gaining ahead of Wall Street's open, but that doesn't change the fact that the stock is still in a strong downtrend. However, the purchases by people closely associated with the company are certainly improving investor sentiment. Source: xStation